CMCR Study States that the Current Schedule I Classification of Marijuana is Arguable

WSJ Team July 16, 2012 0

The Center for Medicinal Cannabis Research (CMCR) had released a study published in the Open Neurology Journal stating that the current classification of marijuana as a schedule 1 drug is arguable. The study went on to say that there is real evidence that marijuana has  positive medical uses and is a safe drug. It also states that the current classification of marijuana is an obstacle to there being any real progressive research on the subject.

The CMCR has conducted some of the most extensive research being done on the subject of marijuana being used as a medical drug. Their research findings conclude that it is useful for, “control of nausea and vomiting and weight gain” in the chronically ill. New research shows that drug may even be beneficial in the treatment of peripheral neuropathy and muscle spasticity in patients with multiple sclerosis and other such conditions.

While the study does say there is some potential for abuse; that abuse is less likely than with some pain medications. Also, unlike pain and mood altering medications (such as codeine and xanax) there have been no reported cases of fatal overdoses.  Any side effects reported have been dose related and are mild to moderate in severity.

The study comes on the heels of DEA Administrator Michele Leonhart’s testimony before a House oversight hearing on the subject.  Leonhart argues that  marijuana is just as harmful as heroin and meth (both of these are also Schedule 1 drugs).

Advocates for the legal medical use of marijuana applaud these findings but still more needs to be done. Steph Sherer, Executive Director of Americans for Safe Access (ASA) is unhappy with the Obama’s administration’s current stance on the issue. Sherer is hopeful that these findings will encourage needed changes in attitudes. Said Sherer in a statement, “With the backing of such strongly worded recommendations, patients remain hopeful that the federal government will recognize the science and reclassify marijuana”

The ASA has filed a suit against the Obama administration for denying a petition to reclassify marijuana. There is also a bill  (HR 1983) pending in Congress that calls for the rescheduling of the drug.

Leave A Response »